BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Marques-Neto LM, Trentini MM, das Neves RC, Resende DP, Procopio VO, da Costa AC, Kipnis A, Mortari MR, Schwartz EF, Junqueira-Kipnis AP. Antimicrobial and Chemotactic Activity of Scorpion-Derived Peptide, ToAP2, against Mycobacterium massiliensis. Toxins (Basel) 2018;10:E219. [PMID: 29848960 DOI: 10.3390/toxins10060219] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 2.3] [Reference Citation Analysis]
Number Citing Articles
1 Valdez-Velázquez LL, Cid-Uribe J, Romero-Gutierrez MT, Olamendi-Portugal T, Jimenez-Vargas JM, Possani LD. Transcriptomic and proteomic analyses of the venom and venom glands of Centruroides hirsutipalpus, a dangerous scorpion from Mexico. Toxicon 2020;179:21-32. [PMID: 32126222 DOI: 10.1016/j.toxicon.2020.02.021] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
2 Ahmadi S, Knerr JM, Argemi L, Bordon KCF, Pucca MB, Cerni FA, Arantes EC, Çalışkan F, Laustsen AH. Scorpion Venom: Detriments and Benefits. Biomedicines 2020;8:E118. [PMID: 32408604 DOI: 10.3390/biomedicines8050118] [Cited by in Crossref: 12] [Cited by in F6Publishing: 8] [Article Influence: 6.0] [Reference Citation Analysis]
3 Sudadech P, Roytrakul S, Kaewprasert O, Sirichoat A, Chetchotisakd P, Kanthawong S, Faksri K. Assessment of in vitro activities of novel modified antimicrobial peptides against clarithromycin resistant Mycobacterium abscessus. PLoS One 2021;16:e0260003. [PMID: 34780520 DOI: 10.1371/journal.pone.0260003] [Reference Citation Analysis]
4 Martin-Serrano Á, Gómez R, Ortega P, de la Mata FJ. Nanosystems as Vehicles for the Delivery of Antimicrobial Peptides (AMPs). Pharmaceutics 2019;11:E448. [PMID: 31480680 DOI: 10.3390/pharmaceutics11090448] [Cited by in Crossref: 33] [Cited by in F6Publishing: 31] [Article Influence: 11.0] [Reference Citation Analysis]
5 Cesa-Luna C, Muñoz-Rojas J, Saab-Rincon G, Baez A, Morales-García YE, Juárez-González VR, Quintero-Hernández V. Structural characterization of scorpion peptides and their bactericidal activity against clinical isolates of multidrug-resistant bacteria. PLoS One 2019;14:e0222438. [PMID: 31710627 DOI: 10.1371/journal.pone.0222438] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
6 Ibarra-Valencia MA, Espino-Solis GP, Estrada BE, Corzo G. Immunomodulatory Responses of Two Synthetic Peptides against Salmonella Typhimurium Infection. Molecules 2021;26:5573. [PMID: 34577046 DOI: 10.3390/molecules26185573] [Reference Citation Analysis]
7 Mahlapuu M, Björn C, Ekblom J. Antimicrobial peptides as therapeutic agents: opportunities and challenges. Crit Rev Biotechnol 2020;40:978-92. [PMID: 32781848 DOI: 10.1080/07388551.2020.1796576] [Cited by in Crossref: 30] [Cited by in F6Publishing: 26] [Article Influence: 15.0] [Reference Citation Analysis]
8 Cid-Uribe JI, Meneses EP, Batista CVF, Ortiz E, Possani LD. Dissecting Toxicity: The Venom Gland Transcriptome and the Venom Proteome of the Highly Venomous Scorpion Centruroides limpidus (Karsch, 1879). Toxins (Basel) 2019;11:E247. [PMID: 31052267 DOI: 10.3390/toxins11050247] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 4.3] [Reference Citation Analysis]
9 Luo X, Ye X, Ding L, Zhu W, Zhao Z, Luo D, Liu N, Sun L, Chen Z. Identification of the scorpion venom-derived antimicrobial peptide Hp1404 as a new antimicrobial agent against carbapenem-resistant Acinetobacter baumannii. Microb Pathog 2021;157:104960. [PMID: 34022355 DOI: 10.1016/j.micpath.2021.104960] [Reference Citation Analysis]
10 Bento CM, Gomes MS, Silva T. Looking beyond Typical Treatments for Atypical Mycobacteria. Antibiotics (Basel) 2020;9:E18. [PMID: 31947883 DOI: 10.3390/antibiotics9010018] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 5.0] [Reference Citation Analysis]
11 da Mata ECG, Ombredane A, Joanitti GA, Kanzaki LIB, Schwartz EF. Antiretroviral and cytotoxic activities of Tityus obscurus synthetic peptide. Arch Pharm (Weinheim) 2020;353:e2000151. [PMID: 32686134 DOI: 10.1002/ardp.202000151] [Reference Citation Analysis]